MedTrace Logo

The Prevalence of Hyper-Lp(a)-Emia in the PMMHRI-Lp(a) Registry

NCT06610669 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-09-24

No results posted yet for this study

Summary

The PMMHRI-Lp(a)-Registry is a non-interventional, single-center registry conducted in the Polish Mother's Memorial Hospital Research Institute (PMMHRI). The PMMHRI-Lp(a)-Registry was established in January 2022. Since then, all consecutive patients of the Department of Cardiology and Adult Congenital Heart Diseases, Department of Endocrinology, and outpatient cardiology and endocrinology clinics with the measured Lp(a) concentration have been included.

Conditions

  • Lipoprotein(a), Hyper-Lp(a)-Emia

Sponsors & Collaborators

  • Polish Mother Memorial Hospital Research Institute

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2028-01-31
Completion
2028-06-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06610669 on ClinicalTrials.gov